| Serial Number | 79299814 |
| Word Mark | TMEXPLORE |
| Filing Date | Thursday, October 1, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 14, 2021 |
| Registration Number | 6481164 |
| Registration Date | Tuesday, September 14, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 29, 2021 |
| Pseudo Mark | TM EXPLORE |
| Goods and Services | Medical analysis services relating to the clinical diagnostic and ongoing evaluation, analysis and study of a cancer or tumor microenvironment; medical assistance; health services namely health assessment services; pharmaceutical compound evaluation services; therapeutic services in the field of oncology diagnosis; medical diagnostics, diagnostics in the field of medicine; genetic and/or tissue analysis services for medical purposes; medical testing services for diagnostic or treatment purposes; medical services for the detection, qualification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis |
| Goods and Services | Research, development, technical design and scientific testing services in the field of oncology; research and development of new products for third parties in the pharmaceutical field; industrial analysis and research services in the field of oncology; biomarker analysis services for pharmaceutical research purposes; microbiological testing services for medical and scientific research; testing biomarkers for clinical trials; tests in laboratories namely testing of cancer related biomarkers; laboratory research services concerning pharmaceutical products; development of testing methods namely development of testing specifications and procedures for the characterization of tumors and tumor microenvironment; research, development, technical design, testing, analysis services and consultation services related thereto in the fields of immunology and oncology; Research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the fields of biomarker analysis, immune repertoire analysis, tissue and genome analysis; design and development of software in the field of biology |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 14, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 14, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Veracyte |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Party Name | HalioDx |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Party Name | HalioDx |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Friday, December 11, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 18, 2020 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 13, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, May 4, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 5, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, May 23, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 26, 2021 | ASSIGNED TO EXAMINER |
| Friday, March 12, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 17, 2021 | REFUSAL PROCESSED BY MPU |
| Thursday, March 18, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, April 5, 2021 | REFUSAL PROCESSED BY IB |
| Saturday, February 12, 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, March 4, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Friday, March 4, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Sunday, April 10, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, August 21, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, December 14, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, June 9, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 29, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 29, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | REGISTERED-PRINCIPAL REGISTER |